Incyte's vision is to become a leading drug discovery and development company by building a proprietary product pipeline of novel small molecule drugs. We have an experienced management and discovery team. Our assets, experience and prior success in bringing important new drugs to market put us in a strong position to make a difference in healthcare, improve the lives of patients and build significant sustainable value for our shareholders.

We have assembled a competitive and talented drug discovery and development team, which has extensive experience in a number of therapeutic areas. We have active internal drug discovery programs focused on the identification of novel small molecule drugs for oncology, inflammation and diabetes.

Incyte's corporate headquarters is located in Wilmington, Delaware.